Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 35,341Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/rd/neurocrine-review-highlights-key-differences-between-tardive-dyskinesia-drugs-18317

INDPHARMAPOST
23 Nov 2025

https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-publication-of-landmark-narrative-review-on-fda-approved-vmat2-inhibitors-demonstrating-unique-profile-of-ingrezza-valbenazine-capsules-302620990.html

PR NEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/07/3184014/0/en/AUSTEDO-deutetrabenazine-tablets-and-AUSTEDO-XR-deutetrabenazine-extended-release-tablets-Demonstrate-Positive-Real-world-Impact-with-Patients-Reporting-Improvement-in-Involuntary-.html

GLOBENEWSWIRE
07 Nov 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215971

FDA
26 Dec 2024

https://www.businesswire.com/news/home/20240601407405/en

BUSINESSWIRE
01 Jun 2024

https://www.businesswire.com/news/home/20240425312754/en

BUSINESSWIRE
29 May 2024